Press Room

News / Nov 11, 2019

Portugal’s Annual "St. Martin's Day" & 60th Anniversary Dinner

Hovione Macau organized the St. Martin's Day in our manufacturing facility in Macau

60th Anniversary Dinner Macau | Hovione

St. Martin's Day “ was held on 11th November, to commemorate the harvest of crops & the moment when the grapes become young wine. For many years, the Portuguese have celebrated the “St. Martin's Day “as a way of connecting all Portuguese around the world.

Since 2000, Hovione has been organizing this event to commemorate St. Martin's Day at Macau site’s garden. This year Hovione is also celebrating its 60th anniversary, the 40th anniversary of Hovione Hong Kong and the 35th anniversary of Hovione Macau.

To finalize we all toasted to Macau and to this wonderful celebration.

Portugal’s Annual "St. Martin's Day" & 60th Anniversary Dinner | Hovione

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025